A Phase IV Clinical Trial to Study the Safety, Tolerability and Efficacy of Tinefcon in Patients With Plaque Psoriasis
NCT01373567
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
298
Enrollment
INDUSTRY
Sponsor class
Conditions
Plaque Psoriasis
Interventions
DRUG:
TINEFCON
Sponsor
Piramal Enterprises Limited